First Trust Advisors L.P. > First Trust Exchange-Traded AlphaDEX Fund
First Trust Health Care AlphaDEX Fund
$1.29B
Avg Monthly Net Assets
$1.27B
Total Assets
$862K
Total Liabilities
$1.27B
Net Assets
First Trust Health Care AlphaDEX Fund is an Exchange-Traded Fund in First Trust Exchange-Traded AlphaDEX Fund
from First Trust Advisors L.P.,
based in Illinois,
United States of America.
The fund has one share class
and monthly net assets of $1.29B.
On September 23rd, 2024 it reported 79 holdings, the largest
being Centene Corp (2.5%), Universal Health Services Inc (2.5%) and Viatris Inc (2.4%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| First Trust Health Care AlphaDEX Fund | C000048900 | ARCX | FXH |
Holdings
From latest NPORT-P, filed September 23rd, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $11M | 104K | 0.87 |
| AbbVie Inc | Long | Equity-common | US | $5M | 29K | 0.43 |
| Agilent Technologies Inc | Long | Equity-common | US | $12M | 83K | 0.93 |
| Align Technology Inc | Long | Equity-common | US | $5M | 21K | 0.38 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $26M | 111K | 2.08 |
| Amgen Inc | Long | Equity-common | US | $23M | 69K | 1.81 |
| Avantor Inc | Long | Equity-common | US | $6M | 238K | 0.50 |
| Baxter International Inc | Long | Equity-common | US | $12M | 322K | 0.91 |
| Becton Dickinson & Co | Long | Equity-common | US | $11M | 46K | 0.88 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $6M | 18K | 0.49 |
| Bio-Techne Corp | Long | Equity-common | US | $6M | 70K | 0.45 |
| Biogen Inc | Long | Equity-common | US | $14M | 65K | 1.10 |
| Bruker Corp | Long | Equity-common | US | $16M | 237K | 1.28 |
| Cardinal Health Inc | Long | Equity-common | US | $16M | 154K | 1.23 |
| Centene Corp | Long | Equity-common | US | $31M | 406K | 2.47 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $18M | 73K | 1.41 |
| Chemed Corp | Long | Equity-common | US | $16M | 28K | 1.26 |
| Cigna Group/The | Long | Equity-common | US | $23M | 65K | 1.79 |
| Cooper Cos Inc/The | Long | Equity-common | US | $5M | 58K | 0.43 |
| Danaher Corp | Long | Equity-common | US | $6M | 20K | 0.44 |
| DaVita Inc | Long | Equity-common | US | $27M | 194K | 2.10 |
| DENTSPLY SIRONA Inc | Long | Equity-common | US | $5M | 203K | 0.43 |
| Doximity Inc | Long | Equity-common | US | $11M | 385K | 0.85 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $7M | 117K | 0.58 |
| Elevance Health Inc | Long | Equity-common | US | $26M | 50K | 2.09 |
| Eli Lilly & Co | Long | Equity-common | US | $24M | 30K | 1.89 |
| Encompass Health Corp | Long | Equity-common | US | $16M | 176K | 1.29 |
| Enovis Corp | Long | Equity-common | US | $16M | 335K | 1.26 |
| Envista Holdings Corp | Long | Equity-common | US | $5M | 303K | 0.41 |
| Exelixis Inc | Long | Equity-common | US | $22M | 958K | 1.77 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $12M | 138K | 0.92 |
| Globus Medical Inc | Long | Equity-common | US | $5M | 74K | 0.42 |
| HCA Healthcare Inc | Long | Equity-common | US | $24M | 67K | 1.92 |
| Henry Schein Inc | Long | Equity-common | US | $17M | 236K | 1.34 |
| Hologic Inc | Long | Equity-common | US | $12M | 145K | 0.93 |
| Humana Inc | Long | Equity-common | US | $15M | 41K | 1.16 |
| Incyte Corp | Long | Equity-common | US | $23M | 355K | 1.82 |
| Insulet Corp | Long | Equity-common | US | $10M | 53K | 0.82 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $12M | 157K | 0.98 |
| Intuitive Surgical Inc | Long | Equity-common | US | $22M | 48K | 1.70 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $16M | 318K | 1.24 |
| IQVIA Holdings Inc | Long | Equity-common | US | $13M | 51K | 0.99 |
| Jazz Pharmaceuticals PLC | Long | Equity-common | US | $28M | 252K | 2.20 |
| Johnson & Johnson | Long | Equity-common | US | $16M | 104K | 1.29 |
| Labcorp Holdings Inc | Long | Equity-common | US | $11M | 53K | 0.90 |
| Medpace Holdings Inc | Long | Equity-common | US | $25M | 65K | 1.97 |
| Medtronic PLC | Long | Equity-common | IE | $15M | 192K | 1.22 |
| Merck & Co Inc | Long | Equity-common | US | $10M | 87K | 0.78 |
| Molina Healthcare Inc | Long | Equity-common | US | $17M | 51K | 1.37 |
| MSILF Treasury Portfolio | Long | Short-term investment vehicle | US | $655K | 655K | 0.05 |
| Natera Inc | Long | Equity-common | US | $25M | 249K | 2.01 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $22M | 156K | 1.75 |
| Organon & Co | Long | Equity-common | US | $23M | 1M | 1.80 |
| Perrigo Co PLC | Long | Equity-common | IE | $24M | 838K | 1.87 |
| Pfizer Inc | Long | Equity-common | US | $6M | 180K | 0.43 |
| Premier Inc | Long | Equity-common | US | $30M | 1M | 2.39 |
| QIAGEN NV | Long | Equity-common | NL | $16M | 368K | 1.29 |
| Quest Diagnostics Inc | Long | Equity-common | US | $22M | 157K | 1.77 |
| R1 RCM Inc | Long | Equity-common | US | $5M | 402K | 0.41 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $22M | 20K | 1.75 |
| ResMed Inc | Long | Equity-common | US | $12M | 56K | 0.95 |
| Revvity Inc | Long | Equity-common | US | $13M | 103K | 1.02 |
| Roivant Sciences Ltd | Long | Equity-common | US | $28M | 3M | 2.18 |
| Royalty Pharma PLC | Long | Equity-common | US | $23M | 816K | 1.82 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $24M | 170K | 1.91 |
| STERIS PLC | Long | Equity-common | US | $5M | 23K | 0.43 |
| Stryker Corp | Long | Equity-common | US | $15M | 44K | 1.15 |
| Teleflex Inc | Long | Equity-common | US | $16M | 72K | 1.26 |
| Tenet Healthcare Corp | Long | Equity-common | US | $30M | 202K | 2.39 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $6M | 9K | 0.44 |
| United Therapeutics Corp | Long | Equity-common | US | $26M | 84K | 2.09 |
| UnitedHealth Group Inc | Long | Equity-common | US | $24M | 42K | 1.92 |
| Universal Health Services Inc | Long | Equity-common | US | $31M | 146K | 2.46 |
| Veralto Corp | Long | Equity-common | US | $106.56 | 1 | 0.00 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $23M | 46K | 1.80 |
| Viatris Inc | Long | Equity-common | US | $31M | 3M | 2.41 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $5M | 15K | 0.37 |
| Zimmer Biomet Holdings Inc | Long | Equity-common | US | $22M | 198K | 1.74 |
| Zoetis Inc | Long | Equity-common | US | $5M | 29K | 0.41 |
Address
First Trust Exchange-Traded AlphaDEX Fund
120 East Liberty Drive
Suite 400
Wheaton
Illinois
60187
United States of America
Websites
Directors
Robert F. Keith
Niel B. Nielson
Richard E. Erickson
Denise M. Keefe
Thomas R. Kadlec
James A. Bowen
Bronwyn Wright
Transfer Agents
The Bank of New York Mellon
Pricing Services
LSEG Pricing Service
ICE Data Pricing & Reference Data, LLC
Bloomberg L.P.
Custodians
The Bank of New York Mellon
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Brokers
SUSQUEHANNA FINANCIAL GROUP, LLLP
CITADEL SECURITIES LLC
CANTOR FITZGERALD & CO.
MIZUHO SECURITIES USA LLC
OLD MISSION MARKETS LLC